Hims & Hers (NYSE: HIMS) policy chief sells shares under 10b5-1 plan

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) reported an insider transaction by director and Chief Policy Officer Deborah M. Autor. On August 18, 2026, she sold 16,773 shares of Class A Common Stock at $27.85 per share in an open-market or private transaction pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026, and now holds 48,961 shares directly.

Insider Trade Summary 10b5-1

Net Seller: 16,773 shares

Net Sell 1 txn

Insider Autor Deborah M.

Role Chief Policy Officer

Sold 16,773 shs ($467K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock F1	16,773	$27.85	$467K

Holdings After Transaction: Class A Common Stock — 48,961 shares (Direct)

Footnotes (1)

1. F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

Key Figures

Shares sold: 16,773 shares of Class A Common Stock Sale price per share: $27.85 per share Shares held after transaction: 48,961 shares +1 more

4 metrics

Shares sold 16,773 shares of Class A Common Stock Sale on August 18, 2026

Sale price per share $27.85 per share Sale of Class A Common Stock on August 18, 2026

Shares held after transaction 48,961 shares Direct ownership following the August 18, 2026 sale

Rule 10b5-1 plan adoption date May 20, 2026 Plan under which the reported sale was effected

Key Terms

Class A Common Stock, Rule 10b5-1 trading plan, open market or private transaction

3 terms

Class A Common Stock financial

"16,773 shares of Class A Common Stock at $27.85 per share"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Rule 10b5-1 trading plan regulatory

"sales were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open market or private transaction financial

"Sale in open market or private transaction"

FAQ

What insider transaction did HIMS report for Deborah M. Autor?

Hims & Hers Health, Inc. reported that Deborah M. Autor sold 16,773 shares of Class A Common Stock on August 18, 2026 at $27.85 per share in an open-market or private transaction.

How many HIMS shares does Deborah M. Autor hold after this transaction?

After the reported sale, Deborah M. Autor directly holds 48,961 shares of Hims & Hers Health, Inc. Class A Common Stock.

Was the HIMS insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the sale was effected under a Rule 10b5-1 trading plan adopted on May 20, 2026 by the reporting person.

What was the sale price per share in the latest HIMS Form 4?

The reported sale price was $27.85 per share for Hims & Hers Health, Inc. Class A Common Stock.

What is Deborah M. Autor’s role at Hims & Hers Health, Inc. (HIMS)?

Deborah M. Autor is reported as both a director and the Chief Policy Officer of Hims & Hers Health, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/20/2026 - 04:31 PM Accepted by SEC EDGAR 08/20/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Autor Deborah M.

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Policy Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/18/2026		S(1)		16,773	D	$27.85	48,961	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Deborah M Autor	08/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)